Cargando…
Influenza vaccine efficacy induced by orally administered recombinant baculoviruses
Although vaccine delivery through the oral route remains the most convenient and safest way for mass immunization purposes, this method is limited by the requirement for large antigen doses and low vaccine efficacy. In this study, we generated recombinant baculoviruses (rBVs) expressing influenza he...
Autores principales: | Basak, Swarnendu, Kang, Hae-Ji, Lee, Su-Hwa, Chu, Ki-Back, Moon, Eun-Kyung, Quan, Fu-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252623/ https://www.ncbi.nlm.nih.gov/pubmed/32459823 http://dx.doi.org/10.1371/journal.pone.0233520 |
Ejemplares similares
-
Simple and rapid plaque assay for recombinant baculoviruses expressing influenza hemagglutinin
por: Basak, Swarnendu, et al.
Publicado: (2021) -
Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021) -
Protective Immunity Induced by Virus-Like Particle Containing Merozoite Surface Protein 9 of Plasmodium berghei
por: Lee, Su-Hwa, et al.
Publicado: (2020) -
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18
por: Yoon, Keon-Woong, et al.
Publicado: (2022) -
Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei
por: Kim, Min-Ju, et al.
Publicado: (2022)